DOCSLIB.ORG

List of Genes Associated with Nasopharyngeal Carcinoma Gene Symbol Gene Name Reference

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Genes Associated with Nasopharyngeal Carcinoma Gene Symbol Gene Name Reference List of genes associated with nasopharyngeal carcinoma Gene symbol Gene name Reference LOC344967 Acyl-CoA thioesterase 7 pseudogene 16423998 ITGA9 Integrin subunit alpha 9 19478819, 26372814 EBNA1 Nuclear antigen EBNA-1 22815911, 24190575, 24460960, 24753359, 28810605 LMP1 Latent membrane protein LMP-1 22815911, 14678988, 23868181, 27049918, 23939952 LMP2 Membrane protein LMP-2A 17980397, 24630965, 26292668, 22815911 BARF1 BARF1 protein BARF1 22815911, 15778977, 29562599, 23996634, 22406129 FHIT Fragile histidine triad 22815911, 23534718 EGFR Epidermal growth factor receptor 23416081, 26339373, 28129778, 18367518, 27203742 COX2 Cytochrome c oxidase subunit II 23416081, 25553117, 26261650, 28435473, 28732079 CCNE1 Cyclin E1 23416081 hTERT Telomerase reverse transcriptase 23416081, 24648937, 21233856, 24615621, 25153197 MMP2 Matrix metallopeptidase 2 23416081, 28129778, 17607721, 25066400, 26546460 MMP9 Matrix metallopeptidase 9 23416081, 23409137, 22957092, 24243817, 28380444 NF-κB Nuclear factor kappa B subunit 1 23416081, 28380444, 23868181, 28969015, 26172457 VEGF Vascular endothelial growth factor A 23416081, 28243126, 26275421, 21233856, 26717040 WNT3 Wnt family member 3 23416081 URG4/URGCP Upregulator of cell proliferation 29775749, 28315691 TNFAIP2 TNF alpha induced protein 2 21057457, 23975427 FAS Fas cell surface death receptor 16473667, 26275421 TRIM26 Tripartite motif containing 26 29956500 PTEN Phosphatase and tensin homolog 24604064, 25365510, 24632578, 20053927, 27840403 CDK5 Cyclin dependent kinase 5 26339373 P53 Tumor protein p53 26339373, 26893866, 24262659, 24632578, 28081741 CDH13 Cadherin 13 16807071 HOXA2 Homeobox A2 24243817 HER2 erb-b2 receptor tyrosine kinase 2 11850071 STAT3 Signal transducer and activator of transcription 3 25365510, 16516862, 18367518, 27538493, 26779625 IL-6 Interleukin 6 25365510, 28732079, 25970784 AKT AKT serine/threonine kinase 1 25365510, 14678988, 29936709, 27270423, 24632578 cdc42 Cell division cycle 42 14678988, 24877689 c-Jun Jun proto-oncogene, AP-1 transcription factor subunit 14678988, 27270423, 27533465, 25571870, 22727408 Bcl-3 BCL3, transcription coactivator 14678988, 18367518 IFN-γ Interferon gamma 23272637, 28810605 ING4 Inhibitor of growth family member 4 25571952 ANGPT1 Angiopoietin 1 26722421 LMP2A Membrane protein LMP-2A 17980397, 24630965, 26292668 EBNA2 Nuclear antigen EBNA-2 17980397 Notch1 Notch 1 17980397, 26621837, 24281414, 28581676 Notch3 Notch 3 22009689, 27035429 RUNX3 Runt related transcription factor 3 17201146 P16 Cyclin dependent kinase inhibitor 2A 17201146, 26294655, 24460960, 21445878, 27326252 RASSF1A Ras association domain family member 1 17201146, 25196065, 26443805, 11358799, 20042089 hMLH1 MutL homolog 1 17201146 Annexin A1 Annexin A1 28355254, 25322804 S100A9 S100 calcium binding protein A9 28355254 Vimentin Vimentin 28355254, 25823923, 23688988 FBLN2 Fibulin 2 21743496, 22360856 ECM Multimerin 1 21743496 BLU Zinc finger MYND-type containing 10 25347745, 22727408, 28029652, 22360856 β-catenin Catenin beta 1 29552214, 29764469, 29536130, 28569772, 26497204 Wnt Protein Wnt-2 29552214, 23649311, 29764469, 29536130, 27769064 XRCC1 X-ray repair cross complementing 1 24175791, 24940494, 25025378, 27356695, 25481674 OGG1 8-oxoguanine DNA glycosylase 24175791, 29121049 APE1 Apurinic/apyrimidinic endodeoxyribonuclease 1 24175791 HLA-E Major histocompatibility complex, class I, E 26896927 AGO2 Argonaute RISC catalytic component 2 26545861 ARHGAP42 Rho GTPase activating protein 42 29936709 PI3K Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha 29936709, 27270423, 28644386, 25126743, 26698246 CCND1 Cyclin D1 16166286, 27270423, 28581676, 28969015, 22009689 PIN1 Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 23269625 Cav-1 Caveolin 1 21965789 CELF2 CUGBP Elav-like family member 2 26314850 IL-1b Interleukin 1 beta 18289837, 26391153 IL-10 Interleukin 10 23898109 IL-18 Interleukin 18 24066061, 18555694 LAPTM4B Lysosomal protein transmembrane 4 beta 23345117 DC-SIGN CD209 molecule 28694559, 21067616 IL-2 Interleukin 2 20438365 GSTM1 Glutathione S-transferase mu 1 26893866, 18628429 APEX1 Apurinic/apyrimidinic endodeoxyribonuclease 1 28464393 XRCC3 X-ray repair cross complementing 3 24940494, 24453273 BEX3 brain expressed X-linked 3 28083995 OCT4 POU class 5 homeobox 1 28083995 Ets-1 ETS proto-oncogene 1, transcription factor 2752597, 28672814 Pim-3 Pim-3 proto-oncogene, serine/threonine kinase 2752597 SSRP1 Structure specific recognition protein 1 2752597 BRCC3 BRCA1/BRCA2-containing complex subunit 3 26024915 BRD7 Bromodomain containing 7 15137061, 19111069 E2F3 E2F transcription factor 3 15137061, 25630654, 27461945 KRAS KRAS proto-oncogene, GTPase 15137061, 28581676, 25701793, 21878506, 28857155 MEK Mitogen-activated protein kinase kinase 7 15137061 REK TYRO3 protein tyrosine kinase 15137061 Rb RB transcriptional corepressor 1 15137061, 20053927 E2F1 E2F transcription factor 1 15137061, 20053927 ATM ATM serine/threonine kinase 24262659, 29230817, 27883284 Chk2 Checkpoint kinase 2 24262659 Chk1 Checkpoint kinase 1 24262659, 26025928, 24117075 Caspase 12 Caspase 12 28380444 CD44 CD44 molecule 22887934, 24073846, 27809309 CIP4 Thyroid hormone receptor interactor 10 22591637, 23883608 CDH4 Cadherin 4 28129778, 2821940 CFTR Cystic fibrosis transmembrane conductance regulator 21665361 MTAP Methylthioadenosine phosphorylase 27769067 CACNA2D3 Calcium voltage-gated channel auxiliary subunit alpha2delta 3 26656376 CMYC MYC proto-oncogene, bHLH transcription factor 23649311 MMP7 Matrix metallopeptidase 7 23649311, 28969015, 21233856, 29052525, 10685630 SNAIL Snail family transcriptional repressor 1 23649311, 22957092, 23128850, 28656063 PDK1 Pyruvate dehydrogenase kinase 1 23649311, 26497204 MIPOL1 Mirror-image polydactyly 1 29764469, 26547584, 30001734 p21(CDKN1A) Cyclin dependent kinase inhibitor 1A 19667180 p27 (KIP1) Cyclin dependent kinase inhibitor 1B 19667180, 25265349, 29434867, 23783436, 29052525 BTG1 BTG anti-proliferation factor 1 19667180, 23783436, 25749514, 28315691, 23783436 ET1 Endothelin 1 29536130 PDCD4 Programmed cell death 4 29536130, 28199751, 28199751 HGF Hepatocyte growth factor (Homo sapiens) 27270423 Met MET proto-oncogene, receptor tyrosine kinase 26345996 KAI1 CD82 molecule 26345996, 26795575, 25611392, 25965822 NPCEDRG Nicolin 1 25789023, 28583320 HHATL Hedgehog acyltransferase like 20821255 BI-1 Transmembrane BAX inhibitor motif containing 6 16234092 MDM2 MDM2 proto-oncogene 24648937, 21545297 CLPTM1L CLPTM1 like 24632578, 23677067, 27883284, 20398418, 20395212 IDH2 Isocitrate dehydrogenase [NADP(+)] 2, mitochondrial 26621837, 24615621 MAP3K1 Mitogen-activated protein kinase kinase kinase 1 28581676 CDKN2A Cyclin dependent kinase inhibitor 2A 28581676 SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 28581676, 26275421, 12800147, 23790641, 28445979 RAD51L1 RAD51 paralog B 28581676 BRCA1 BRCA1, DNA repair associated 21368091 TP53BP1 Tumor protein p53 binding protein 1 21368091, 28857155 EBNA3A Nuclear antigen EBNA-3A 21368091 BZLF1 Protein Zta 26969667 BRLF1 Protein Rta 26969667, 8212572, 23409137, 27185626 BMRF1 DNA polymerase processivity subunit 26969667, 29108278, 22641235, 27185626 BRCA2 BRCA2, DNA repair associated 26969667 p50 Hypothetical protein 28857155 MYB MYB proto-oncogene, transcription factor 23868181, 18367518 BCL2 BCL2, apoptosis regulator 23868181, 22260379 Bcl3 BCL3, transcription coactivator 23868181, 22009689, 26795575, 25031780, 28969015 RelB RELB proto-oncogene, NF-kB subunit 23868181 TRAF3 TNF receptor associated factor 3 23868181, 28452850 TRAF2 TNF receptor associated factor 2 23868181 NFKBIA NFKB inhibitor alpha 23868181 A20 TNF alpha induced protein 3 23868181, 27647909 NRP-1 Neuropilin 1 23868181, 28969015 OPN Secreted phosphoprotein 1 26755049 CDK4 Cyclin dependent kinase 4 24913806 CYP2E1 Cytochrome P450 family 2 subfamily E member 1 24771220, 25630654, 26383521, 26559153, 24168228 CYB5R2 Cytochrome b5 reductase 2 9274915, 11389775, 8547826, 25481674 FOS Fos proto-oncogene, AP-1 transcription factor subunit 24338690, 26275421 PIK3R1 Phosphoinositide-3-kinase regulatory subunit 1 26275421 ITGB3 Integrin subunit beta 3 26275421 ITGB5 Integrin subunit beta 5 26275421 IGF1 Insulin like growth factor 1 26275421 TEK TEK receptor tyrosine kinase 26275421 TGFBR1 Transforming growth factor beta receptor 1 26275421 NKG2D NKG2D protein (Macaca mulatta) 26275421 FKHRL1 Forkhead box O3 26418951, 28452850 GSK3β Glycogen synthase kinase 3 beta 25749514 Sox2 SRY-box 2 25749514, 27916418, 28569772, 27769064, 27623076 ULBP4 Retinoic acid early transcript 1E 25749514, 29463902 ASS1 Argininosuccinate synthase 1 28159927 PEDF Serpin family F member 1 23897555 LRP6 LDL receptor related protein 6 28569772 DEPDC1 DEP domain containing 1 28569772 CCNB1 Cyclin B1 28969015 CCNB2 Cyclin B2 28969015 NFBD1 Mediator of DNA damage checkpoint 1 28969015 CCNL1 Cyclin L1 26247734, 27334757, 28081741 PTK2 Protein tyrosine kinase 2 29927011 DLC-1 DLC1 Rho GTPase activating protein 29927011 TSG Twisted gastrulation BMP signaling modulator 1 23908159, 22824824 ECRG4 Chromosome 2 open reading frame 40 23908159 ATOH8 Atonal bHLH transcription factor 8 27119734, 27119734, 25707757 Cx43 Gap junction protein alpha 1 27049918 Sp1 Sp1 transcription factor 17306607 ZEB1 Zinc finger E-box binding homeobox 1 27698878, 22260379, 27185626, 26922862, 25161098 CRKL CRK like proto-oncogene, adaptor protein 26936585, 24190575 ETS2 ETS proto-oncogene 2, transcription factor
Load more

Recommended publications
  • 2017.08.28 Anne Barry-Reidy Thesis Final.Pdf
    REGULATION OF BOVINE β-DEFENSIN EXPRESSION THIS THESIS IS SUBMITTED TO THE UNIVERSITY OF DUBLIN FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 2017 ANNE BARRY-REIDY SCHOOL OF BIOCHEMISTRY & IMMUNOLOGY TRINITY COLLEGE DUBLIN SUPERVISORS: PROF. CLIONA O’FARRELLY & DR. KIERAN MEADE TABLE OF CONTENTS DECLARATION ................................................................................................................................. vii ACKNOWLEDGEMENTS ................................................................................................................... viii ABBREVIATIONS ................................................................................................................................ix LIST OF FIGURES............................................................................................................................. xiii LIST OF TABLES .............................................................................................................................. xvii ABSTRACT ........................................................................................................................................xix Chapter 1 Introduction ........................................................................................................ 1 1.1 Antimicrobial/Host-defence peptides ..................................................................... 1 1.2 Defensins................................................................................................................. 1 1.3 β-defensins .............................................................................................................
    [Show full text]
  • Bioinformatics Applications Through Visualization of Variations on Protein
    1 Bioinformatics applications through visualization of variations on protein structures, comparative functional genomics, and comparative modeling for protein structure studies A dissertation presented by Alper Uzun to The Department of Biology In partial fulfillment of the requirements for the degree of Doctor of Philosophy in the field of Biology Northeastern University Boston, Massachusetts July 2009 2 ©2009 Alper Uzun ALL RIGHTS RESERVED 3 Bioinformatics applications through visualization of variations on protein structures, comparative functional genomics, and comparative modeling for protein structure studies by Alper Uzun ABSTRACT OF DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology in the Graduate School of Arts and Sciences of Northeastern University, July, 2009 4 Abstract The three-dimensional structure of a protein provides important information for understanding and answering many biological questions in molecular detail. The rapidly growing number of sequenced genes and related genomic information is intensively accumulating in the biological databases. It is significantly important to combine biological data and developing bioinformatics tools while information of protein sequences, structures and DNA sequences are exponentially growing. On the other hand, especially the number of known protein sequences is much larger than the number of experimentally solved protein structures. However the experimental methods cannot always be applied or protein structures
    [Show full text]
  • Open Dogan Phdthesis Final.Pdf
    The Pennsylvania State University The Graduate School Eberly College of Science ELUCIDATING BIOLOGICAL FUNCTION OF GENOMIC DNA WITH ROBUST SIGNALS OF BIOCHEMICAL ACTIVITY: INTEGRATIVE GENOME-WIDE STUDIES OF ENHANCERS A Dissertation in Biochemistry, Microbiology and Molecular Biology by Nergiz Dogan © 2014 Nergiz Dogan Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2014 ii The dissertation of Nergiz Dogan was reviewed and approved* by the following: Ross C. Hardison T. Ming Chu Professor of Biochemistry and Molecular Biology Dissertation Advisor Chair of Committee David S. Gilmour Professor of Molecular and Cell Biology Anton Nekrutenko Professor of Biochemistry and Molecular Biology Robert F. Paulson Professor of Veterinary and Biomedical Sciences Philip Reno Assistant Professor of Antropology Scott B. Selleck Professor and Head of the Department of Biochemistry and Molecular Biology *Signatures are on file in the Graduate School iii ABSTRACT Genome-wide measurements of epigenetic features such as histone modifications, occupancy by transcription factors and coactivators provide the opportunity to understand more globally how genes are regulated. While much effort is being put into integrating the marks from various combinations of features, the contribution of each feature to accuracy of enhancer prediction is not known. We began with predictions of 4,915 candidate erythroid enhancers based on genomic occupancy by TAL1, a key hematopoietic transcription factor that is strongly associated with gene induction in erythroid cells. Seventy of these DNA segments occupied by TAL1 (TAL1 OSs) were tested by transient transfections of cultured hematopoietic cells, and 56% of these were active as enhancers. Sixty-six TAL1 OSs were evaluated in transgenic mouse embryos, and 65% of these were active enhancers in various tissues.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • TF Activation Profiling Plate Array II Signosis, Inc
    Signosis, Inc. Innovative Plate Assay Solutions TF Activation Profiling Plate Array II Catalog Number: FA-1002 (For Research Use Only) Introduction Materials Provided with the Kit Transcription factors (TFs) are a group of cellular proteins that play essential roles in regulating gene Component Qty Store at expression. They act as sensors to monitor cellular 96-Well Plates (with 2 RT changes and convert signals into gene expression. aluminum adhesive seal) Often, a specific cellular signal pathway can activate Isolation Columns 2 RT multiple TFs. The expression of a specific gene can Elution Buffer 400µL RT also be under the control of multiple TFs. Thus, TF Plate Hybridization Buffer 20mL RT monitoring the activation of multiple TFs 5X Plate Hybridization Wash 60mL RT simultaneously is critical to understanding the Buffer molecular mechanism of cellular regulation underlying 5X Detection Wash Buffer 60mL RT cell signaling and gene expression. Signosis, Inc.’s TF Blocking Buffer 60mL RT Activation Profiling Plate Array II is used for Filter Wash Buffer 5mL 4°C monitoring 96 different TFs simultaneously from one Filter Binding Buffer 1mL 4°C sample. Substrate A 2mL 4°C Substrate B 2mL 4°C Principle of the assay Streptavidin-HRP Conjugate 40µL 4°C Substrate Dilution Buffer 16mL 4°C Signosis, Inc.’s TF Activation Profiling Plate Array II TF Binding Buffer Mix 60µL -20°C is used for monitoring the activation of multiple TFs TF Probe Mix II 20µL -20°C simultaneously. With this technology a series of biotin-labeled probes are made based on the consensus sequences of TF DNA-binding sites.
    [Show full text]
  • ELF2 Antibody - N-Terminal Region Rabbit Polyclonal Antibody Catalog # AI10026
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 ELF2 antibody - N-terminal region Rabbit Polyclonal Antibody Catalog # AI10026 Specification ELF2 antibody - N-terminal region - Product Information Application WB Primary Accession Q15723 Other Accession Q15723-3, NP_006865, NM_006874 Reactivity Human, Mouse, Rat, Rabbit, Dog, Guinea Pig, Horse, Bovine Predicted Human, Mouse, ELF2 antibody - N-terminal region (AI10026) Rat, Rabbit, in Hum. Fetal Heart cells using Western Blot Chicken, Dog, Host: Rabbit Guinea Pig, Horse, Bovine Target Name: ELF2 Host Rabbit Sample Tissue: Human Fetal Heart Clonality Polyclonal Antibody Dilution: 1.0μg/ml Calculated MW 57 kDa KDa ELF2 antibody - N-terminal region - Additional Information Gene ID 1998 Alias Symbol EU32, NERF, NERF-2, NERF-1A, NERF-1B, NERF-1a,b Other Names ETS-related transcription factor Elf-2, ELF2 antibody - N-terminal region (AI10026) E74-like factor 2, New ETS-related factor, in Hum. Fetal Lung cells using Western Blot ELF2 {ECO:0000312|EMBL:AAF671951} Host: Rabbit Target Name: ELF2 Target/Specificity Sample Tissue: Human Fetal Lung The ELF2 gene encodes a protein that Antibody Dilution: 1.0μg/ml physically interacts with AML1 and mediates opposing effects on AML1-mediated transcription of the B cell-specific blk gene. Format Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Reconstitution & Storage Add 50 ul of distilled water. Final anti-ELF2 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose.
    [Show full text]
  • Interindividual Regulation of the BCRP/ABCG2 Transporter in Term Human Placentas
    DMD Fast Forward. Published on January 31, 2018 as DOI: 10.1124/dmd.117.079228 This article has not been copyedited and formatted. The final version may differ from this version. DMD #79228 Title Page Interindividual Regulation of the BCRP/ABCG2 Transporter in Term Human Placentas Kristin M Bircsak, Jamie E Moscovitz, Xia Wen, Faith Archer, Poi Yu Sofia Yuen, Moiz Mohammed, Naureen Memon, Barry I Weinberger, Laura M Saba, Anna M Vetrano, Lauren M Aleksunes Downloaded from Department of Pharmacology and Toxicology, Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, Piscataway, NJ, USA (K.M.B., J.E.M., X.W., L.M.A.), dmd.aspetjournals.org Department of Pediatrics, Rutgers University Robert Wood Johnson Medical School, New Brunswick, NJ, USA (F.A., P.Y.S.Y, M.M., N.M., A.M.V.), Hofstra Northwell School of Medicine, Cohen Children’s Medical Center of New York, New Hyde Park, NY, USA (B.I.W.), at ASPET Journals on October 2, 2021 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA (L.S.), Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, USA (L.M.A.), Lipid Center, Rutgers, The State University of New Jersey, Piscataway, NJ, USA (L.M.A.) 1 DMD Fast Forward. Published on January 31, 2018 as DOI: 10.1124/dmd.117.079228 This article has not been copyedited and formatted. The final version may differ from this version. DMD #79228 Running Title Page Running title: Interindividual
    [Show full text]
  • Homeobox A10 Promotes the Proliferation and Invasion of Bladder Cancer Cells Via Regulation of Matrix Metalloproteinase‑3
    ONCOLOGY LETTERS 18: 49-56, 2019 Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase‑3 CHUNLEI LIU1*, MINGZHU GE2*, JUN MA1*, YANHUI ZHANG1, YANHUI ZHAO1 and TAO CUI1 Departments of 1Urology and 2Ultrasound, Qingdao Central Hospital, Qingdao, Shandong 266042, P.R. China Received February 9, 2018; Accepted January 31, 2019 DOI: 10.3892/ol.2019.10312 Abstract. Homeobox A10 (HOXA10) belongs to the family Smoking and obesity are risk factors for BC (2), and genetic of HOX genes, which are closely connected with embryonic mutations and abnormal protein expression serve important development and serve important roles in various tumors. roles in the genesis, development and progression of BC (4). However, the role of HOXA10 in bladder cancer (BC) remains Therefore, exploring new anomalous molecules involved in unclear. In the present study, the role of HOXA10 in BC and the development of BC may advance the understanding of the underlying mechanisms by which it promotes the disease the mechanisms behind this disease and contribute to the progression were investigated. Immunohistochemical analysis improvement of treatment strategies. demonstrated that the expression of the HOXA10 protein Homeobox A10 (HOXA10) belongs to the family of HOX was significantly higher in BC tissues as compared with that genes, which are classified into four subgroups, namely HOX in adjacent normal tissues. Subsequent statistical analysis A-D (5), and are closely connected with embryonic develop- revealed that upregulation of HOXA10 was significantly ment (6). HOXA10 encodes a DNA-binding transcription factor associated with the pathological grade and clinical stage of that serves vital roles in regulating gene expression, viability BC patients.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Single-Cell RNA Sequencing Analysis of Human Neural Grafts Revealed Unexpected Cell Type Underlying the Genetic Risk of Parkinson’S Disease
    Single-cell RNA Sequencing Analysis of Human Neural Grafts Revealed Unexpected Cell Type Underlying the Genetic Risk of Parkinson’s Disease Yingshan Wang1, Gang Wu2 1 Episcopal High School, 1200 N Quaker Ln, Alexandria, VA, USA, 22302 2 Fujian Sanbo Funeng Brain Hospital; Sanbo Brain Hospital Capital Medical University Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder, affecting more than 6 million patients globally. Though previous studies have proposed several disease-related molecular pathways, how cell-type specific mechanisms contribute to the pathogenesis of PD is still mostly unknown. In this study, we analyzed single-cell RNA sequencing data of human neural grafts transplanted to the midbrains of rat PD models. Specifically, we performed cell-type identification, risk gene screening, and co-expression analysis. Our results revealed the unexpected genetic risk of oligodendrocytes as well as important pathways and transcription factors in PD pathology. The study may provide an overarching framework for understanding the cell non- autonomous effects in PD, inspiring new research hypotheses and therapeutic strategies. Keywords Parkinson’s Disease; Single-cell RNA Sequencing; Oligodendrocytes; Cell Non-autonomous; Co- expression Analysis; Transcription Factors 1 Table of Contents 1. Introduction ................................................................................................................................. 3 2. Methods......................................................................................................................................
    [Show full text]